Use of statin drugs was associated with improved mortality in older nursing home residents, regardless of dementia status, a new study showed. The study is among […]

When added to corticosteroids, treatment with the investigational agent givinostat led to statistically and clinical meaningful benefits in ambulatory children with Duchenne muscular dystrophy (DMD) compared […]

The US Food and Drug Administration (FDA) has approved the first gene therapy for metachromatic leukodystrophy (MLD), a rare and debilitating genetic disease affecting the brain […]

Black patients are nearly 50% less likely to receive genetic evaluation and testing for neurologic disorders compared with White patients, a new study showed. Investigators found […]

Three genetically targeted drugs for Duchenne muscular dystrophy (DMD) — eteplirsen, golodirsen, and casimersen — cost the US health care system more than $3 billion between […]

Epilepsy was linked to a significantly increased the risk for hospitalization and death from COVID-19 early in the pandemic, while healthcare utilization rates in this patient […]

More than one in 10 cases of multiple sclerosis (MS) begin after age 50, with more rapid progression to disability and less exposure to and benefit […]

Stroke, Alzheimer’s disease (AD), and other neurological conditions are now the leading cause of health loss and disability around the world, affecting nearly half of the […]

Skipping meals, mood and anxiety disorders, as well as vaping and substance use, all raise the risk for frequent recurrent headaches in children and adolescents, new […]